Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale Chief Executive Officer sold 6,900 shares at an average $13.35 ($92,115)
  2. 4 Open-market sale Chief Executive Officer sold 4,800 shares at an average $14.91 ($71,568)
  3. 4 Open-market sale EVP & Chief Financial Officer sold 4,000 shares at an average $15.11 ($60,440)
  4. 4 Open-market sale Director sold 1,184 shares at $15.25 ($18,056)
  5. 4 Exercise or conversion Director acquired 1,602 shares (option exercise)
  6. 4 Exercise or conversion Chief Executive Officer acquired 5,908 shares (option exercise)
  7. 4 Open-market sale EVP, R&D & Chief Scientific Of sold 7,604 shares at $14.99 ($113,984)
  8. 4 Open-market sale EVP & Chief R & QA Officer sold 3,873 shares at $15.25 ($59,063)
  9. 4 Open-market sale EVP & Chief Strategy Officer sold 12,674 shares at an average $15.16 ($192,098)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale Chief Executive Officer sold 7,200 shares at an average $17.56 ($126,405)
  13. 4 Open-market sale EVP, R&D & Chief Scientific Of sold 6,000 shares at $17.28 ($103,680)
  14. 4 Open-market sale Chief Executive Officer sold 7,200 shares at an average $17.03 ($122,598)
  15. 4 Grant or award Chief Tech. Operations Officer acquired 7,500 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Chief Executive Officer sold 16,000 shares at an average $20.06 ($320,944)
  18. 4 Open-market sale EVP & Chief Financial Officer sold 14,000 shares at an average $20.65 ($289,045)
  19. 4 Open-market sale Chief Executive Officer sold 30,800 shares at an average $19.38 ($596,808)
  20. 4 Open-market sale EVP, R&D & Chief Scientific Of sold 6,000 shares at $19.60 ($117,600)

Page 22 of 33 · 645 filings